Table 5 Factors affecting overall survival among studied cases
Variables | 1 year | 5 years | Test of significance | P value |
|---|---|---|---|---|
Gender | ||||
Male | 83.1% | 71.4% | 0.858 | 0.345 |
Female | 73.8% | 58.9% | ||
Age | ||||
≤ 60 | 86.2% | 71.4% | 2.248 | 0. 134 |
> 60 | 70.1% | 59.4% | ||
HCV seropositivity | ||||
Negative | 79.8% | 70.1% | 0.602 | 0.438 |
Positive | 75.5% | 56.2% | ||
B symptoms | ||||
Absent | 78.1% | 70% | 0.752 | 0.386 |
Present | 78.8% | 59.1% | ||
BM infiltration (N = 93) | ||||
No | 84.3% | 71.6% | 5.381 | 0.02* |
Yes | 70% | 50.5% | ||
Hans classification | ||||
GC | 80.6% | 67.4% | 0.011 | 0.918 |
Non-GC | 77.6% | 64.8% | ||
IPI risk | ||||
Low and low intermediate | 93.5% | 80.3% | 10.65 | 0.001* |
High intermediate and high | 64.5% | 51.2% | ||
P53 expression (N = 85) | ||||
No over expression | 78.6% | 61.4% | 0.139 | 0.71 |
Over expression | 83.1% | 75.5% | ||
Double expresser | ||||
No | 80.4% | 69.8% | 2.005 | 0.157 |
Yes | 73.9% | 52.3% | ||
Triple expresser | ||||
No | 78.7% | 65.9% | 0.471 | 0.493 |
Yes | 75% | – | ||
PD-L1 expression | ||||
Low | 88.9% | 88.9% | 6.729 | 0.009* |
High | 74.3% | 52.6% | ||